Lupus
Overview
Pathogenesis
Diagnosis
Therapy/Surgery
Complications & Secondary Illness
Research
Clinical Trials
- A Randomized, Double-Blind, Placebo-Controlled, Single Dose-Escalation And Multiple Dose Extension Trial Of NNC 0152-0000-0001 Administered I.V or S.C.. in Subjects with Systemic Lupus Erythematosus
- A Randomized, Double Blind, Placebo Controlled, Multicenter Prospective Dose Finding Phase II/III Study with Atacicept Given Subcutaneously to Subjects having Recently Experienced a Flare of SLE3
- Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter Study To Evaluate The Efficacy and Safety of Two Doses of Ocrelizumab in Patients With WHO or ISN Class III or IV Nephritis Due To Systemic Lupus Erythematosus.
- Autoimmune Disease Registry and Repository
- PROMISSE: Predictors of Pregnancy Outcome: Biomarkers in Anti-Phospholipid Antibody Syndrome (APS) and Systemic Lupus Erythematosus (SLE)
- Pilot and Feasibility Study of Modafinil Treatment to Improve Cognitive Efficiency in SLE Patients
- A Phase 1b Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation study with an open-label extension to evaluate the safety and tolerability of multiple IV doses of Medi-545, a fully Human Anti-interferon-alpha Monoclonal Antibody,
- Fc Receptor Function in Normals and Systemic Lupus Erythematosus (SLE)
- MINDFULL: A Randomized, Controlled Pilot Study of a Cognitive Rehabilitation Intervention Program in Systemic Lupus Erythematosus Patients